38 Pfizer

$9,591 million

2005 Rank/Value
31 / $9,981 million

-4% change from 2005

Based in U.S.

Sold its over-the-counter unit to focus on developing new prescription drugs—a smart move as powerhouse brands such as Lipitor face generic competition.

Photo by Bloomberg News